KNC Laboratories Co (6568.T) Stock Price

KNC Laboratories Co Price

CLOSED
1,180.00
​
Market closed

Over the last 10 years KNC Laboratories Co grew revenue by 7.2% annually, reaching 9.09 B JPY. Earnings per share have grown at 21.7% per year over the last 10 years. For KNC Laboratories Co, the net margin of 8.4% is broadly stable versus 8.6% a few years ago. At today's price the dividend yield works out to roughly 4.24%. The payout ratio is around 22% of earnings. The dividend has grown at 9.1% per year over the past 8 years.

KNC Laboratories Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KNC Laboratories Co business model & stock analysis

KNC Laboratories Co., Ltd. generates revenue by developing and producing organic chemical products for research, development, and manufacturing applications. The company supplies essential samples and products to support product development, manufacturing, and sales activities, focusing on chemical intermediates and materials used in medicine and information electronics. Key product categories include display materials, semiconductor manufacturing chemicals, herbicides, fungicides, and drug substances and intermediates, which are sold to industries requiring specialized chemical solutions. The firm's target segments consist of pharmaceutical manufacturers, electronics producers, and agricultural chemical developers who rely on organic chemical intermediates for their production processes. These customers purchase KNC's products to enhance their own research and development capabilities and to support manufacturing operations. The company's focus on organic chemical solutions for medicine and information electronics positions it as a key supplier in these specialized markets. KNC Laboratories' business model centers on providing tailored chemical products and manufacturing method examinations to its clients. By offering a comprehensive range of organic chemical products, including display materials and semiconductor chemicals, the company meets the diverse needs of its industrial clients. The firm's research and development activities ensure continuous innovation in its product portfolio, supporting long-term relationships with customers in the pharmaceutical, electronics, and agricultural sectors.

Frequently asked questions about KNC Laboratories Co

5 analysts currently rate the KNC Laboratories Co stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the KNC Laboratories Co share trades at 6.67 EUR (1,180.00 JPY).

The revenue of KNC Laboratories Co is 9.09 B JPY. This figure is based on current financial data and reflects the company's business performance.

The profit of KNC Laboratories Co is 766.20 M JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of KNC Laboratories Co is currently 11.92. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the KNC Laboratories Co stock.

The price-to-sales ratio (P/S) of KNC Laboratories Co is currently 1.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the KNC Laboratories Co stock.

The Eulerpool Quality Score for KNC Laboratories Co is 5/10.

The ISIN of KNC Laboratories Co is JP3290400005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of KNC Laboratories Co is 6568.T. The ticker symbol is used to trade KNC Laboratories Co shares on the stock exchange.

Fair ValueTerminal
1,156.40 JPY
Over-/UndervaluationTerminal
Fairly valued
Industry
Chemicals
Number of shares
Employees
Revenue per Employee
31.25 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website kncweb.co.jp
Country
Currency
JPY
Initial public offering
Mar 15, 2018
ISIN
JP3290400005
Cusip
J34117101
Market capitalization
9.18 B JPYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2027
5.66
P/S
P/Se
0.76
EV/EBIT
10.35
P/B Ratio
0.65
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
4.33 %
Dividend
Dividend yield
4.24 %
Est. Dividend Yield
4.77 %
Payout Ratio
22.40 %
Dividend growth Ø5Y
—
Dividend payments per year
2
Dividend paid since
8 years
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
15.32 %
Last updated Nov 13, 2026, 3:46 AM

KNC Laboratories Co Peer Group

KNC Laboratories Co FIGI

6568:JP · BBG0016Y86S46568:JT · BBG00K18VZ776568:JJ · BBG00K18VZJ46568:JE · BBG00K18VZM06568:JI · BBG00K18VZN96568:JU · BBG00K18VZP76568:JW · BBG00K18VZQ66568:JV · BBG0193RCG61